Home |
Climate Change Project |
Table of Contents |
Courses | Search |
![]()
From the U.S. House of Representatives Downloadable U.S. Code
[uscode.house.gov]
[Laws in effect as of January 5, 1999]
[CITE: 42USC300aa-14]
TITLE 42 - THE PUBLIC HEALTH AND WELFARE
CHAPTER 6A - PUBLIC HEALTH SERVICE
SUBCHAPTER XIX - VACCINES
Part 2 - National Vaccine Injury Compensation Program
subpart a - program requirements
-HEAD-
Sec. 300aa-14. Vaccine Injury Table
-STATUTE-
(a) Initial table
The following is a table of vaccines, the injuries, disabilities,
illnesses, conditions, and deaths resulting from the administration
of such vaccines, and the time period in which the first symptom or
manifestation of onset or of the significant aggravation of such
injuries, disabilities, illnesses, conditions, and deaths is to
occur after vaccine administration for purposes of receiving
compensation under the Program:
VACCINE INJURY TABLE
---------------------------------------------------------------------
---------------------------------------------------------------------
I. DTP; P; DTP/Polio
Combination; or Any
Other Vaccine
Containing Whole
Cell Pertussis
Bacteria, Extracted
or Partial Cell
Bacteria, or
Specific Pertussis
Antigen(s).
Illness, disability, Time period for
injury, or first symptom or
condition covered: manifestation of
onset or of
significant
aggravation after
vaccine
administration:
A. Anaphylaxis or 24 hours
anaphylactic shock
B. Encephalopathy 3 days
(or encephalitis)
C. Shock-collapse or 3 days
hypotonic-
hyporesponsive
collapse
D. Residual seizure 3 days
disorder in
accordance with
subsection (b)(2)
E. Any acute Not applicable
complication or
sequela (including
death) of an
illness,
disability, injury,
or condition
referred to above
which illness,
disability, injury,
or condition arose
within the time
period prescribed
II. Measles, mumps,
rubella, or any
vaccine containing
any of the
foregoing as a
component; DT; Td;
or Tetanus Toxoid.
A. Anaphylaxis or 24 hours
anaphylactic shock
B. Encephalopathy 15 days (for mumps,
(or encephalitis) rubella, measles,
or any vaccine
containing any of
the foregoing as a
component). 3 days
(for DT, Td, or
tetanus toxoid).
C. Residual seizure 15 days (for mumps,
disorder in rubella, measles,
accordance with or any vaccine
subsection (b)(2) containing any of
the foregoing as a
component). 3 days
(for DT, Td, or
tetanus toxoid).
D. Any acute Not applicable
complication or
sequela (including
death) of an
illness,
disability, injury,
or condition
referred to above
which illness,
disability, injury,
or condition arose
within the time
period prescribed
III. Polio Vaccines
(other than
Inactivated Polio
Vaccine).
A. Paralytic polio
- in a non- 30 days
immunodeficient
recipient
- in an 6 months
immunodeficient
recipient
- in a vaccine- Not applicable
associated community
case
B. Any acute Not applicable
complication or
sequela (including
death) of an
illness,
disability, injury,
or condition
referred to above
which illness,
disability, injury,
or condition arose
within the time
period prescribed
IV. Inactivated Polio
Vaccine.
A. Anaphylaxis or 24 hours
anaphylactic shock
B. Any acute Not applicable
complication or
sequela (including
death) of an
illness,
disability, injury,
or condition
referred to above
which illness,
disability, injury,
or condition arose
within the time
period prescribed
-------------------------------
(b) Qualifications and aids to interpretation
The following qualifications and aids to interpretation shall
apply to the Vaccine Injury Table in subsection (a) of this
section:
(1) A shock-collapse or a hypotonic-hyporesponsive collapse may
be evidenced by indicia or symptoms such as decrease or loss of
muscle tone, paralysis (partial or complete), hemiplegia or
hemiparesis, loss of color or turning pale white or blue,
unresponsiveness to environmental stimuli, depression of
consciousness, loss of consciousness, prolonged sleeping with
difficulty arousing, or cardiovascular or respiratory arrest.
(2) A petitioner may be considered to have suffered a residual
seizure disorder if the petitioner did not suffer a seizure or
convulsion unaccompanied by fever or accompanied by a fever of
less than 102 degrees Fahrenheit before the first seizure or
convulsion after the administration of the vaccine involved and
if -
(A) in the case of a measles, mumps, or rubella vaccine or
any combination of such vaccines, the first seizure or
convulsion occurred within 15 days after administration of the
vaccine and 2 or more seizures or convulsions occurred within 1
year after the administration of the vaccine which were
unaccompanied by fever or accompanied by a fever of less than
102 degrees Fahrenheit, and
(B) in the case of any other vaccine, the first seizure or
convulsion occurred within 3 days after administration of the
vaccine and 2 or more seizures or convulsions occurred within 1
year after the administration of the vaccine which were
unaccompanied by fever or accompanied by a fever of less than
102 degrees Fahrenheit.
(3)(A) The term ''encephalopathy'' means any significant
acquired abnormality of, or injury to, or impairment of function
of the brain. Among the frequent manifestations of
encephalopathy are focal and diffuse neurologic signs, increased
intracranial pressure, or changes lasting at least 6 hours in
level of consciousness, with or without convulsions. The
neurological signs and symptoms of encephalopathy may be
temporary with complete recovery, or may result in various
degrees of permanent impairment. Signs and symptoms such as high
pitched and unusual screaming, persistent unconsolable crying,
and bulging fontanel are compatible with an encephalopathy, but
in and of themselves are not conclusive evidence of
encephalopathy. Encephalopathy usually can be documented by slow
wave activity on an electroencephalogram.
(B) If in a proceeding on a petition it is shown by a
preponderance of the evidence that an encephalopathy was caused
by infection, toxins, trauma, or metabolic disturbances the
encephalopathy shall not be considered to be a condition set
forth in the table. If at the time a judgment is entered on a
petition filed under section 300aa-11 of this title for a
vaccine-related injury or death it is not possible to determine
the cause, by a preponderance of the evidence, of an
encephalopathy, the encephalopathy shall be considered to be a
condition set forth in the table. In determining whether or not
an encephalopathy is a condition set forth in the table, the
court shall consider the entire medical record.
(4) For purposes of paragraphs (2) and (3), the terms
''seizure'' and ''convulsion'' include grand mal, petit mal,
absence, myoclonic, tonic-clonic, and focal motor seizures and
signs. If a provision of the table to which paragraph (1), (2),
(3), or (4) applies is revised under subsection (c) or (d) of
this section, such paragraph shall not apply to such provision
after the effective date of the revision unless the revision
specifies that such paragraph is to continue to apply.
(c) Administrative revision of table
(1) The Secretary may promulgate regulations to modify in
accordance with paragraph (3) the Vaccine Injury Table. In
promulgating such regulations, the Secretary shall provide for
notice and opportunity for a public hearing and at least 180 days
of public comment.
(2) Any person (including the Advisory Commission on Childhood
Vaccines) may petition the Secretary to propose regulations to
amend the Vaccine Injury Table. Unless clearly frivolous, or
initiated by the Commission, any such petition shall be referred to
the Commission for its recommendations. Following -
(A) receipt of any recommendation of the Commission, or
(B) 180 days after the date of the referral to the Commission,
whichever occurs first, the Secretary shall conduct a rulemaking
proceeding on the matters proposed in the petition or publish in
the Federal Register a statement of reasons for not conducting such
proceeding.
(3) A modification of the Vaccine Injury Table under paragraph
(1) may add to, or delete from, the list of injuries, disabilities,
illnesses, conditions, and deaths for which compensation may be
provided or may change the time periods for the first symptom or
manifestation of the onset or the significant aggravation of any
such injury, disability, illness, condition, or death.
(4) Any modification under paragraph (1) of the Vaccine Injury
Table shall apply only with respect to petitions for compensation
under the Program which are filed after the effective date of such
regulation.
(d) Role of Commission
Except with respect to a regulation recommended by the Advisory
Commission on Childhood Vaccines, the Secretary may not propose a
regulation under subsection (c) of this section or any revision
thereof, unless the Secretary has first provided to the Commission
a copy of the proposed regulation or revision, requested
recommendations and comments by the Commission, and afforded the
Commission at least 90 days to make such recommendations.
(e) Additional vaccines
(1) Vaccines recommended before August 1, 1993
By August 1, 1995, the Secretary shall revise the Vaccine
Injury Table included in subsection (a) of this section to
include -
(A) vaccines which are recommended to the Secretary by the
Centers for Disease Control and Prevention before August 1,
1993, for routine administration to children,
(B) the injuries, disabilities, illnesses, conditions, and
deaths associated with such vaccines, and
(C) the time period in which the first symptoms or
manifestations of onset or other significant aggravation of
such injuries, disabilities, illnesses, conditions, and deaths
associated with such vaccines may occur.
(2) Vaccines recommended after August 1, 1993
When after August 1, 1993, the Centers for Disease Control and
Prevention recommends a vaccine to the Secretary for routine
administration to children, the Secretary shall, within 2 years
of such recommendation, amend the Vaccine Injury Table included
in subsection (a) of this section to include -
(A) vaccines which were recommended for routine
administration to children,
(B) the injuries, disabilities, illnesses, conditions, and
deaths associated with such vaccines, and
(C) the time period in which the first symptoms or
manifestations of onset or other significant aggravation of
such injuries, disabilities, illnesses, conditions, and deaths
associated with such vaccines may occur.
-SOURCE-
(July 1, 1944, ch. 373, title XXI, Sec. 2114, as added Pub. L.
99-660, title III, Sec. 311(a), Nov. 14, 1986, 100 Stat. 3764;
amended Pub. L. 101-239, title VI, Sec. 6601(k), Dec. 19, 1989, 103
Stat. 2290; Pub. L. 103-66, title XIII, Sec. 13632(a)(2), Aug. 10,
1993, 107 Stat. 645.)
-MISC1-
PRIOR PROVISIONS
A prior section 300aa-14, act July 1, 1944, Sec. 2115, was
successively renumbered by subsequent acts and transferred, see
section 238l of this title.
A prior section 2114 of act July 1, 1944, was successively
renumbered by subsequent acts and transferred, see section 238k of
this title.
AMENDMENTS
1993 - Subsec. (e). Pub. L. 103-66 amended heading and text of
subsec. (e) generally. Prior to amendment, text read as follows:
''The Secretary may recommend to Congress revisions of the table to
change the vaccines covered by the table.''
1989 - Subsec. (a). Pub. L. 101-239, Sec. 6601(k)(1), substituted
''(b)(2)'' for ''(c)(2)'' in items I.D. and II.C. in table.
Subsec. (b)(3)(B). Pub. L. 101-239, Sec. 6601(k)(2), substituted
''300aa-11 of this title'' for ''300aa-11(b) of this title''.
EFFECTIVE DATE OF 1989 AMENDMENT
For applicability of amendments by Pub. L. 101-239 to petitions
filed after Dec. 19, 1989, petitions currently pending in which the
evidentiary record is closed, and petitions currently pending in
which the evidentiary record is not closed, with provision for an
immediate suspension for 30 days of all pending cases, see section
6601(s)(1) of Pub. L. 101-239, set out as a note under section
300aa-10 of this title.
REVISIONS OF VACCINE INJURY TABLE
The Vaccine Injury Table as modified by regulations promulgated
by the Secretary of Health and Human Services is set out at 42 CFR
100.3.
Section 13632(a)(3) of Pub. L. 103-66 provided that: ''A revision
by the Secretary under section 2114(e) of the Public Health Service
Act (42 U.S.C. 300aa-14(e)) (as amended by paragraph (2)) shall
take effect upon the effective date of a tax enacted to provide
funds for compensation paid with respect to the vaccine to be added
to the vaccine injury table in section 2114(a) of the Public Health
Service Act (42 U.S.C. 300aa-14(a)).''
-SECREF-
SECTION REFERRED TO IN OTHER SECTIONS
This section is referred to in sections 300aa-25, 300aa-33 of
this title.
FDA/Website Management Staff
Web page created by smc 2000-NOV-14.
The Climate Change and Public Health Law Site
The Best on the WWW Since 1995!
Copyright as to non-public domain materials
See DR-KATE.COM for home hurricane and disaster preparation
See WWW.EPR-ART.COM for photography of southern Louisiana and Hurricane Katrina
Professor Edward P. Richards, III, JD, MPH - Webmaster
Provide Website Feedback - https://www.lsu.edu/feedback
Privacy Statement - https://www.lsu.edu/privacy
Accessibility Statement - https://www.lsu.edu/accessibility